The effect of crocin on weight gain in patients taking clozapine

Phase 3

Recruiting

• Conditions: Weight gain.; Simple obesity NOS; E66.9

• Registration Number: IRCT20211202053250N2
• Lead Sponsor: Mashhad University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 29 August 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 74

Inclusion Criteria

Patients taking clozapine for at least one month before the start of the study with a BMI greater than 25 or weight gain greater than 10%
Age range 20 to 60 years
Patient and guardian consent to participate in the study
No entry of schizoaffective and bipolar patients
No history of allergies to crocin
No pregnancy and lactation
Do not admit patients who are taking drugs that affect weight at the same time
Do not admit patients who are addicted to drugs, stimulants and alcohol
Lack of untreated medical condition affecting weight such as hypothyroidism

Exclusion Criteria

No patient entering below the age range of 20 years and above 60 years
No entry of schizoaffective and bipolar patients
Absence of pregnancy and lactation
Do not admit patients who are taking drugs that affect weight at the same time
Do not admit patients who are addicted to drugs, stimulants and alcohol
Lack of untreated medical condition affecting weight such as hypothyroidism
Patient dissatisfaction to participate in the study

Study & Design

• Study Type: interventional
• Study Design: Not specified